VRH4L: Virtual Reality to Reduce Labor Pain

Sponsor
Clinique Saint-Jean, Bruxelles (Other)
Overall Status
Completed
CT.gov ID
NCT05167383
Collaborator
(none)
41
1
2
3
13.9

Study Details

Study Description

Brief Summary

Background and Goal of Study Labor pain remains an area where different analgesia options are looked for, more specifically non-pharmacological remedies are popular. Hypnosis and virtual reality (VR) have been studied with encouraging results. However, until now, the combination of VR and hypnosis (VRH) has not been assessed during labor, although it has shown promising results in other acute pain areas. The VRH4L study will evaluate the efficacy of Virtual Reality Hypnosis (VRH) in reducing pain during labor. Hypnosis is delivered as a standardized therapeutic intervention through virtual reality, using a digital sedation software (AQUA ®, Oncomfort SA).

For this prospective, interventional parallel group, monocentric randomized controlled trial full term women who were planned for an induction of labor at the St-Jean Hospital in Brussels from March to May 2021 were included. Women with complicated pregnancies and patients with contraindications to VR were excluded.

Patients were randomized in two arms. In the VRH group the patients received a 30-minute session of virtual reality hypnosis when in active labor and had access to standard care. Patients in the control group received only standard care.

Primary outcome was the difference in post intervention pain score between the two arms. Secondary outcomes were the difference in pain score 30 minutes after the intervention, vital signs correlated to pain, satisfaction of the experience, interaction with the midwife and prevalence of side effects. Data was analyzed using the student's T test.

Condition or Disease Intervention/Treatment Phase
  • Device: VRH (Virtual Reality Hypnosis)
  • Behavioral: Standard care
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
41 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective interventional Randomized Controlled TrialProspective interventional Randomized Controlled Trial
Masking:
Single (Investigator)
Masking Description:
The investigator only gets the anonymized prospective data from the patients
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Controlled Monocentric Study Evaluating the Impact of Virtual Reality Hypnosis During Labor
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
May 30, 2021
Actual Study Completion Date :
May 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention VR group

. In the VRH group the patients received a 30-minute session of virtual reality hypnosis when in active labor and had access to standard care.

Device: VRH (Virtual Reality Hypnosis)
Hypnosis is delivered as a standardized therapeutic intervention through virtual reality, using a digital sedation software (AQUA ®, Onfomfort SA).

Behavioral: Standard care
The standard treatment (ST) for labor pain as used in our hospital contains massage, aquatherapy and postural exercises. This is always available for any woman in labor.

Placebo Comparator: Standard treatment

Patients in the control group received only standard care.

Behavioral: Standard care
The standard treatment (ST) for labor pain as used in our hospital contains massage, aquatherapy and postural exercises. This is always available for any woman in labor.

Outcome Measures

Primary Outcome Measures

  1. Post interventional pain scores [T1(before intervention) and T3 (directly after intervention)]

    Primary outcome was the difference in post intervention pain score between the two arms. Difference in Numerical Rating Scale (0 to 10, where 0 is no pain and 10 is maximum pain) pain scores after the intervention between the VRH and Standard care group.

Secondary Outcome Measures

  1. Pain 30 minutes after intervention [T4 (30 min after intervention)]

    Measure of Numerical Rating Scale (0 to 10, where 0 is no pain and 10 is maximum pain) after 30 minutes

  2. Maternal heart rate [T1(before intervention) , T2 (During intervention), T3 (directly after intervention) and T4 (30 min after intervention)]

    Measured heart rate during and after intervention as an absolute value.

  3. Nausea [T1(before intervention) , T3 (directly after intervention) and T4 (30 min after intervention)]

    Nausea and vomiting scores (0-3, 0 = no nausea, 3= nausea and vomiting))

  4. Satisfaction of the mother [T6 (day 1 postpartum)]

    Likert scale (-2,0,2) .-2 is very dissatisfied, 1= dissatisfied, 0= not satisfied, nor dissatisfied, 1= satisfied and 2 is very satisfied

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Age: ≥ 18 and ≤ 45 years

  2. Pregnant with term gestation

  3. Willing to adhere to the rules linked to the use of the VRH headset: turning off mobile phone, visit bathroom in advance, no new visitors and no interference of the partner other than when the woman would ask him so

  4. Provision of written informed consent

  5. Induced labor

Exclusion Criteria:
  1. Complicated pregnancy ( HELLP,…)

  2. Scheduled caesarian delivery

  3. Receipt of epidural analgesia or opioid painkillers before start active labor phase

  4. Low auditory acuity that precludes use of the device

  5. Low visual acuity that precludes use of the device

  6. Head or face wounds precluding use of the device

  7. Schizophrenia

  8. Epilepsy

  9. Dizziness

  10. Non-proficiency in French and/or Dutch (research language)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinique Saint-Jean Brussel Belgium 1000

Sponsors and Collaborators

  • Clinique Saint-Jean, Bruxelles

Investigators

  • Study Chair: Louise Piccart, Dr., Resident Anesthesiologie

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Dr. Arnaud Bosteels, Medical doctor, Clinique Saint-Jean, Bruxelles
ClinicalTrials.gov Identifier:
NCT05167383
Other Study ID Numbers:
  • VRH4L
First Posted:
Dec 22, 2021
Last Update Posted:
Jan 18, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Arnaud Bosteels, Medical doctor, Clinique Saint-Jean, Bruxelles
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2022